24 . 10 .2019
Press release
Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation of Seven New Clinical Studies
24 . 10 .2019
Press release
Fort Worth’s Galderma, Maker of Cetaphil, Presents the 5th Annual Wonder Run 5K and Kids 1K to Benefit Children’s Skin Disease Foundation
21 . 10 .2019
Press release
Face Up To Rosacea: Galderma launches new campaign to empower and equip rosacea patients to discuss the true burden of their disease with a dermatologist
10 . 10 .2019
Press release
Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis
09 . 10 .2019
Press release
Galderma Announces Positive Phase 2 Results for its Proprietary Liquid Formulation of an Investigational Botulinum Toxin and Approval of New State-of-the-Art Manufacturing Facility
07 . 10 .2019
Press release
Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years
02 . 10 .2019
Press release
Galderma to become the world’s largest independent global dermatology company after completion of CHF 10.2 billion carve-out of Nestlé Skin Health
11 . 06 .2019
Press release
Cetaphil® Announces Partnership with Award-Winning Actress, Rachel Brosnahan
16 . 05 .2019
Press release
Nestlé enters into exclusive negotiations to sell Nestlé Skin Health to a consortium led by EQT and ADIA